Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos

计划入组 20 人 · 首次发布于 2012 年 12 月 21 日

Evaluation of the Safety and Efficacy of the DeScribe™ Patch

计划入组 30 人 · 首次发布于 2014 年 11 月 21 日

Clinical Evaluation of 755nm Alexandrite Laser Versus Nanosecond 755nm Alexandrite

首次发布于 2013 年 3 月 14 日

Actos + SYR-322

ATTO-003

ATTO-004

Artios Pharma Ltd.

United Kingdom

Antios Therapeutics, Inc.

United States

Anthos Therapeutics, Inc.

United States

IDEAYA and ATTMOS Partner to Pioneer AI-Driven Drug Discovery for Undruggable Cancer Targets

Novartis Acquires Anthos Therapeutics for $925M, Aims to Advance Novel Blood Thinner Abelacimab

Novartis to Acquire Anthos Therapeutics for $925M, Advancing Novel Stroke Prevention Drug Abelacimab